Navigation Links
Hybrid Molecule Causes Cancer Cells to Self-Destruct

vised the project. “Our insight was to select the sugar partner to serve not just as a passive carrier but as additional ammunition in the fight against cancer.”

The researchers focused on a sugar called N-acetyl-D-mannosamine, or ManNAc, for short. The team created a hybrid molecule by linking ManNAc with butyrate. The hybrid easily penetrates a cell’s surface, then is split apart by enzymes inside the cell. Once inside the cell, ManNAc is processed into another sugar known as sialic acid that plays key roles in cancer biology, while butyrate orchestrates the expression of genes responsible for halting the uncontrolled growth of cancer cells.

Although the study of the exact molecular mechanism is in its early stages, the researchers believe the separate chemical components work together to bolster the cancer-fighting power of butyrate. The double attack triggers cellular suicide, also called apoptosis, in the cancer cells.

To find out whether this butyrate-ManNAc hybrid alone would produce the positive results, the researchers tested three other sugar-butyrate combinations and a butyrate salt compound with no sugar attached. The four other formulas and the butyrate-ManNAc hybrid were each added to lab dishes containing cancer cells. After three to five days, cancer growth had slowed in all of the dishes. After 15 days, however, cancer growth had resumed in dishes treated with four of the compounds. But in samples treated with the butyrate-ManNAc hybrid, all of the cancer cells had died.

The researchers also wanted to find out whether administering the two parts of the hybrid independently would achieve the same result. But in these experiments, the cancer cells did not self-destruct. The researchers suspect this is because the hybrid molecules more easily penetrate the surface of the cell than the individual chemicals. Once the components are inside, the researchers believe the partners help enzymes to resume the normal a
'"/>




Page: 1 2 3

Related medicine news :

1. Hybrid antibodies to protect from small pox infection
2. NHS To Be Reformed By Using A Hybrid Approach
3. Molecular Imaging Of Cancer Now Possible, New Hybrid Virus Produced
4. Hybrid Nanoparticles for Multimodal Medical Imaging
5. New Molecule that can stop the growth of Viruses
6. Puberty may be due to GPR54 gene and KiSS-1 Molecule
7. Molecule responsible for muscle repair identified
8. Molecule aids fight E. Coli Infections
9. Molecule That Aids Bacterial Infections Identified
10. Molecule Behind Multiple Sclerosis Discovered
11. Therapeutic Monoclonal Antibody Production Is More Profitable Than Small Molecule Drugs
Post Your Comments:
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2
...heir ancestors were from and odds are that they kn...olecular Genetics suggests that scientists using t...attention to ancestry when analyzing and interpret...t they know. Or maybe not. A new study published i...
...ns and public safety messages may be the most effe...e the overall safety of New York City subway syste...a University,s Mailman School of Public Health. Su... of mass transit in the U.S. The paper, "Epidemiol...
... extensive,experience on the topic of asbestos law...merging Trends in Asbestos Litigation" to be held ...ills March 9-11, 2009. , The program is bein...aniel Stack of Madison County Circuit Court in,Edw...
...ng a $100 Super Certificate to one lucky donor eve... , , PHILADELPHIA, Dec. 16 With the holida...riends to come together and enjoy this special tim...-bin/prnh/20081216/DC52619LOGO ) , , Donors w...
...udy links maternal prescriptions with child health...s) December 16, 2008 -- Children of mothers who to....5 times higher incidence of asthma when compared ...indings, accompanied by an editorial, appear onlin...
...rsching will,be among 26 float riders in the 6th a... New Year,s Day. This year,s theme, "The Stars of... gift of life possible for others. Kim,Morsching,...ing uses Kevin,s favorite word -- arete --,to desc...
Other Medicine News:Health News:Genome-wide Association Studies Must Account for Ancestry 2Health News:Genome-wide Association Studies Must Account for Ancestry 3Health News:'Don't drink and ride': Improving subway safety 2Health News:Judges, Doctors Featured at Mealey's Asbestos Conference in March 2Health News:Donating Blood Can Help Fill Your Holiday Stockings 2Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 2Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 3Health News:Antacid Medication in Pregnancy May Increase Childhood Asthma 4Health News:Young Athlete's Gift of Life to be Honored on Rose Parade Float 2
(Date:12/4/2009)MARLTON, N.J., Dec. 4 Thermographic Diagnostic Imaging (TDI), part of a Health & Wellness Center in Marlton, New Jersey continues to provide superior quality infrared imaging of the breast, neuro
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Top Three US Bank Chooses CIC Electronic Signature Technology for Branch Wide Deployment 10274 1Top Three US Bank Chooses CIC Electronic Signature Technology for Branch Wide Deployment 10274 2Top Three US Bank Chooses CIC Electronic Signature Technology for Branch Wide Deployment 10274 3Oropharyngeal cancer patients experience post surgery sleep apnea 58952 1ACPM recommends primary care have systems in place for screening and treating depression 58947 1
...ecember 11, 2008, the Joint Advisory Committees of...luding the Drug Safety & Risk Management Advis...nd the Pulmonary-Allergy Drugs Advisory Committee ...asthma medications containing long-acting beta-ago...enefits of AstraZeneca,s SYMBICORT(R) (budesonide/...
...ed risk of death by 13% (P=0.08), despite inclusio...ra therapy , , - In a separate censored analy...Femara, reduction in risk of death was 19% , , ... 1-98 trial reinforces starting with Femara as the..., EAST HANOVER, N.J., Dec. 11 New long-term dat...
Other Medicine Technology:AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 2AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8
...hawing systems are automated, easy to operate and ...vironment by flexible snap-seal pockets which mini... contamination of the water. Offered in two-, four...commodate bags of various sizes. ThermoLine Thawin...
Tuberculosis Ab - Rapid Test
...B5000 Circulatory Support System consists of two p...nced computer system that drives the blood pumps a...port of patients between hospitals. The AB5000 Ven...rting the left, right, or both ventricles of the h...
Salmonella Typhi Antigen - Rapid Test
Medicine Products: